Mutya Harsch - Oct 11, 2021 Form 4 Insider Report for Satsuma Pharmaceuticals, Inc. (STSA)

Role
Director
Signature
/s/ Thomas P. O'Neil as Attorney in Fact for Mutya Harsch
Stock symbol
STSA
Transactions as of
Oct 11, 2021
Transactions value $
$0
Form type
4
Date filed
10/12/2021, 05:17 PM
Previous filing
Oct 1, 2021
Next filing
Jan 4, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STSA Stock Option (Right to Buy) Award $0 +40K $0.00 40K Oct 11, 2021 Common Stock 40K $4.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The award shall vest as to 1/36 of the shares subject to the award on each monthly anniversary from October 11, 2021, subject to continued service through each applicable vesting date